Filip Grabowski
Filip Grabowski has a total of 13 co-authors. Here are the top co-authors by number of shared publications:
- Natalia Rulewska
Provincial Specialist Hospital in Ciechanów: Ciechanów, PL
11 shared publications - Dagmara Neska
Ludwika Błażka Provincial Multi-Specialist Hospital in Inowrocław St. Poznańska 97, 88-100 Inowrocław, Poland
8 shared publications - Adrianna Czyżnikiewicz
Ludwika Błażka Provincial Multi-Specialist Hospital in Inowrocław
7 shared publications - Dominika Prystacka-Szar
Ludwik Rydygier Memorial Specialized Hospital in Kraków
7 shared publications - Jakub Siemko
Ludwika Błażka Provincial Multi-Specialist Hospital in Inowrocław
7 shared publications - Justyna Stadler-Szajda
Ludwika Błażka Provincial Multi-Specialist Hospital in Inowrocław St. Poznańska 97, 88-100 Inowrocław
7 shared publications
Latest Publications
- Open Access
- 13 May 2025
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Revision of total knee arthroplasty in a patient with aseptic loosening caused by reaction to polyethylene – Case Report
Total knee arthroplasty (TKA) is an effective surgical procedure commonly performed to treat degenerative knee diseases. The procedure can lead to complications that necessitate revision surgeries, with aseptic loosening standing out as one of the predominant causes of surgical failure. The case...
- 13 May 2025
- Published by Institute of Rural Health in Journal of Pre-Clinical and Clinical Research
Open AccessRevision of total knee arthroplasty in a patient with aseptic loosening caused by reaction to polyethylene – Case Report
Total knee arthroplasty (TKA) is an effective surgical procedure commonly performed to treat degenerative knee diseases. The procedure can lead to complications that necessitate revision surgeries, with aseptic loosening standing out as one of the predominant causes of surgical failure. The case...
- Open Access
- 10 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 41, 59807
Cupping therapy on low back pain. A systematic review
Low back pain (LBP) encompasses a range of symptoms such as discomfort, muscle tension, tenderness, and stiffness in the area between the lower rib cage and the buttocks. The causes of LBP can be divided into two primary categories: specific low back pain, which has identifiable sources, and non-specific low back pain (NSLBP), which lacks a clear cause. Studies indicate that most patients will experience at least one recurrence of LBP within the span of a year. Additionally, around 5 to 10 percent of acute low back pain cases can progress to chronic low back pain (CLBP). Interestingly, around 90% of LBP instances are not associated with identifiable physical anomalies. This poses a significant challenge for healthcare systems, especially considering the persistent and often unclear nature of these pain conditions. To address lower back pain, three common approaches are used: medications, surgical procedures, and rehabilitation programs. In recent years, there has been a growing trend toward complementary and alternative medicine (CAM) in developed countries, largely due to the side effects associated with traditional treatment methods. The aim of this article is to assess the effectiveness of treating low back pain through cupping. A comprehensive analysis of research papers available on PubMed and Google Scholar was undertaken using the searchterms encompassing the following keywords: cupping therapy, low back pain (LBP), chronic back pain, complementary and alternative medicine (CAM). In traditional medicine, treatment methods typically involve options like non-steroidal anti-inflammatory drugs, opioids, muscle relaxants, steroids, and in some cases, surgery. However, emerging research suggests that cupping therapy could be a promising alternative for managing these conditions. To fully understand how long cupping is effective for alleviating lower back pain (LBP), further studies and appropriate follow-ups are essential.
- 10 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 41, 59807
Open AccessCupping therapy on low back pain. A systematic review
Low back pain (LBP) encompasses a range of symptoms such as discomfort, muscle tension, tenderness, and stiffness in the area between the lower rib cage and the buttocks. The causes of LBP can be divided into two primary categories: specific low back pain, which has identifiable sources, and non-specific low back pain (NSLBP), which lacks a clear cause. Studies indicate that most patients will experience at least one recurrence of LBP within the span of a year. Additionally, around 5 to 10 percent of acute low back pain cases can progress to chronic low back pain (CLBP). Interestingly, around 90% of LBP instances are not associated with identifiable physical anomalies. This poses a significant challenge for healthcare systems, especially considering the persistent and often unclear nature of these pain conditions. To address lower back pain, three common approaches are used: medications, surgical procedures, and rehabilitation programs. In recent years, there has been a growing trend toward complementary and alternative medicine (CAM) in developed countries, largely due to the side effects associated with traditional treatment methods. The aim of this article is to assess the effectiveness of treating low back pain through cupping. A comprehensive analysis of research papers available on PubMed and Google Scholar was undertaken using the searchterms encompassing the following keywords: cupping therapy, low back pain (LBP), chronic back pain, complementary and alternative medicine (CAM). In traditional medicine, treatment methods typically involve options like non-steroidal anti-inflammatory drugs, opioids, muscle relaxants, steroids, and in some cases, surgery. However, emerging research suggests that cupping therapy could be a promising alternative for managing these conditions. To fully understand how long cupping is effective for alleviating lower back pain (LBP), further studies and appropriate follow-ups are essential.
- Open Access
- 10 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 60023
Riluzole’s role in treatment of spinal cord injuries – overview of studies on animals and humans
Injuries in the spinal cord are responsible for disabling a great number of people each year. The primary and secondary damage varies in pathomechanisms, the latter one being heavily associated with excitotoxicity caused by excess extracellular glutamate. Riluzole, a drug used in amyotrophic lateral sclerosis, lowers the amount of released glutamate, thus making it a possible candidate for treatment in spinal cord injuries. Several studies have been performed on animals and humans, although their results do not always align. In controlled environments, when injuries to the neural tissue in the spinal cord are mechanical or ischemic, the drug’s usage shows promising effects in treated rats. Tests on humans are much harder to conduct and so the research has focused on already ill individuals. Their conditions vary, however, and not all of the people could recover, even to a small degree. Further studies need to be performed in order to qualify riluzole as a remedium to injuries of the spinal cord.
- 10 May 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 60023
Open AccessRiluzole’s role in treatment of spinal cord injuries – overview of studies on animals and humans
Injuries in the spinal cord are responsible for disabling a great number of people each year. The primary and secondary damage varies in pathomechanisms, the latter one being heavily associated with excitotoxicity caused by excess extracellular glutamate. Riluzole, a drug used in amyotrophic lateral sclerosis, lowers the amount of released glutamate, thus making it a possible candidate for treatment in spinal cord injuries. Several studies have been performed on animals and humans, although their results do not always align. In controlled environments, when injuries to the neural tissue in the spinal cord are mechanical or ischemic, the drug’s usage shows promising effects in treated rats. Tests on humans are much harder to conduct and so the research has focused on already ill individuals. Their conditions vary, however, and not all of the people could recover, even to a small degree. Further studies need to be performed in order to qualify riluzole as a remedium to injuries of the spinal cord.
- Open Access
- 10 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 58359
Hereditary hemochromatosis: pathogenesis, symptoms, diagnosis and current treatment - literature review
Introduction: Hereditary hemochromatosis is the most common genetic disorder in Northern Europe. It involves an overload of iron in the tissues due to a deficiency of the protein hepcidin. 85-90% of cases are associated with homozygous mutations of the C282Y gene in the HFE gene. Symptoms are nonspecific and include cardiac disorders, liver cirrhosis, hepatocellular carcinoma, diabetes, hypogonadism and sexual dysfunction, and arthritis. The diagnosis of the disease is based on demonstrating elevated serum ferritin levels and transferrin saturation, as well as identifying the mutation responsible for hereditary hemochromatosis. Early diagnosis is crucial in preventing permanent organ complications. Treatment methods include phlebotomy, therapeutic erythrocytophoresis, and the use of iron chelating drugs. Early detected and properly treated hemochromatosis allows for a lifespan comparable to the general population. Aim: The purpose of this article is to provide a comprehensive summary of the etiology, symptoms, diagnosis and treatment of hereditary hemochromatosis with an emphasis on the importance of early detection and treatment of the disease. Review methods: A thorough analysis of several dozen research studies from recent years on hereditary hemochromatosis and its complications was conducted. Studies available in PUBMED were reviewed, the following keywords were used to search for sources: hemochromatosis; iron; hepcidin; phlebotomy; deferoxamine; therapeutic erythrocytapheresis. Conclusion: Hereditary hemochromatosis is a disease that in most patients runs a covert course. If unrecognized and untreated, it carries many life-threatening complications.
- 10 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 58359
Open AccessHereditary hemochromatosis: pathogenesis, symptoms, diagnosis and current treatment - literature review
Introduction: Hereditary hemochromatosis is the most common genetic disorder in Northern Europe. It involves an overload of iron in the tissues due to a deficiency of the protein hepcidin. 85-90% of cases are associated with homozygous mutations of the C282Y gene in the HFE gene. Symptoms are nonspecific and include cardiac disorders, liver cirrhosis, hepatocellular carcinoma, diabetes, hypogonadism and sexual dysfunction, and arthritis. The diagnosis of the disease is based on demonstrating elevated serum ferritin levels and transferrin saturation, as well as identifying the mutation responsible for hereditary hemochromatosis. Early diagnosis is crucial in preventing permanent organ complications. Treatment methods include phlebotomy, therapeutic erythrocytophoresis, and the use of iron chelating drugs. Early detected and properly treated hemochromatosis allows for a lifespan comparable to the general population. Aim: The purpose of this article is to provide a comprehensive summary of the etiology, symptoms, diagnosis and treatment of hereditary hemochromatosis with an emphasis on the importance of early detection and treatment of the disease. Review methods: A thorough analysis of several dozen research studies from recent years on hereditary hemochromatosis and its complications was conducted. Studies available in PUBMED were reviewed, the following keywords were used to search for sources: hemochromatosis; iron; hepcidin; phlebotomy; deferoxamine; therapeutic erythrocytapheresis. Conclusion: Hereditary hemochromatosis is a disease that in most patients runs a covert course. If unrecognized and untreated, it carries many life-threatening complications.
- Open Access
- 5 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 57863
Cannabinoids: Do they alleviate pain in cancer patients?
More than half of cancer patients experience chronic pain, especially those who have the disease in an advanced stage. Cancer is a complex illness that causes substantial morbidity and mortality. The mainstay of traditional pain care is opioids, which, although useful for some people, usually lead to insufficient pain relief and a host of negative side effects, such as opioid-refractory pain and reliance. A growing number of people are interested in alternative treatment choices, including cannabinoids made from the cannabis plant, as a result of these difficulties. This review centers on the endocannabinoid system (ECS), a sophisticated network of cell signals that is essential for controlling a number of physiological and pathological functions, including the feeling of pain. Major cannabinoids including Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are being investigated for their potential to lessen the negative effects of chemotherapy as well as their analgesic and anti-inflammatory qualities. The promising role of cannabis in cancer pain management is highlighted in this review, which also discusses the need for more study to determine their safety, effectiveness, and incorporation into clinical practice. Methods A review of the literature was conducted using the WHO and PubMed databases. Keywords: oncology, chronic pain, pain, endocannabinoid system and cannaboids. A total of 33 papers or websites were included in the review.
- 5 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 57863
Open AccessCannabinoids: Do they alleviate pain in cancer patients?
More than half of cancer patients experience chronic pain, especially those who have the disease in an advanced stage. Cancer is a complex illness that causes substantial morbidity and mortality. The mainstay of traditional pain care is opioids, which, although useful for some people, usually lead to insufficient pain relief and a host of negative side effects, such as opioid-refractory pain and reliance. A growing number of people are interested in alternative treatment choices, including cannabinoids made from the cannabis plant, as a result of these difficulties. This review centers on the endocannabinoid system (ECS), a sophisticated network of cell signals that is essential for controlling a number of physiological and pathological functions, including the feeling of pain. Major cannabinoids including Δ9-tetrahydrocannabinol (THC) and cannabidiol (CBD) are being investigated for their potential to lessen the negative effects of chemotherapy as well as their analgesic and anti-inflammatory qualities. The promising role of cannabis in cancer pain management is highlighted in this review, which also discusses the need for more study to determine their safety, effectiveness, and incorporation into clinical practice. Methods A review of the literature was conducted using the WHO and PubMed databases. Keywords: oncology, chronic pain, pain, endocannabinoid system and cannaboids. A total of 33 papers or websites were included in the review.
- Open Access
- 5 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 57828
The role of physical activity in the treatment of depression
Introduction: Depression contributes significantly to the overall global societal and personal burden of disease. Despite the developments in treatment strategies, the effectiveness of both medication and psychotherapy is not optimal. As theoretical knowledge expands, so does the need for other practical evidence-based interventions. Among them, physical activity (PA) shows a potential therapeutic role. Aim: The aim of this article is to explore the role of PA in the treatment of depression and establish whether it is reasonable to think of physical exercise as a therapeutic intervention in a clinical setting. Review methods: A comprehensive analysis of research papers available on PubMed and Google Scholar was undertaken using the search terms encompassing the following keywords: depressive symptoms / depression / neuropsychiatry / physical activity / exercise / physical health / running therapy / treatment. Conclusion: Physical activity is known to help improve mental health. Exercise therapy is therefore a valuable option in mental health care, both in terms of mental and physical health, and should be considered standard practice for people with depression and/or anxiety disorders. All types of PA and exercise are beneficial. Putting an emphasis on this element of lifestyle when developing intervention plans, treatment programs, and health policy guidelines plays a key factor in providing a multi-dimensional approach to mental healthcare.
- 5 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 57828
Open AccessThe role of physical activity in the treatment of depression
Introduction: Depression contributes significantly to the overall global societal and personal burden of disease. Despite the developments in treatment strategies, the effectiveness of both medication and psychotherapy is not optimal. As theoretical knowledge expands, so does the need for other practical evidence-based interventions. Among them, physical activity (PA) shows a potential therapeutic role. Aim: The aim of this article is to explore the role of PA in the treatment of depression and establish whether it is reasonable to think of physical exercise as a therapeutic intervention in a clinical setting. Review methods: A comprehensive analysis of research papers available on PubMed and Google Scholar was undertaken using the search terms encompassing the following keywords: depressive symptoms / depression / neuropsychiatry / physical activity / exercise / physical health / running therapy / treatment. Conclusion: Physical activity is known to help improve mental health. Exercise therapy is therefore a valuable option in mental health care, both in terms of mental and physical health, and should be considered standard practice for people with depression and/or anxiety disorders. All types of PA and exercise are beneficial. Putting an emphasis on this element of lifestyle when developing intervention plans, treatment programs, and health policy guidelines plays a key factor in providing a multi-dimensional approach to mental healthcare.
- Open Access
- 5 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 57856
Treatment of Fibromyalgia - duloxetine or pregabalin?
Introduction: Fibromyalgia (FM) is a complex and chronic condition characterized by widespread pain, fatigue, and disrupted sleep, often accompanied by mood disturbances and cognitive difficulties. The pathophysiology of FM involves heightened pain sensitivity, altered neurotransmitter levels, and neurochemical imbalances, including elevated substance P and glutamate. Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), has demonstrated efficacy in managing FM symptoms, particularly pain, functional impairment, and quality of life. Pregabalin, another widely used FM medication, reduces pain by modulating calcium channels and neurotransmitter release, improving sleep and reducing fatigue. Comparative studies indicate that duloxetine may offer broader benefits, including reduced healthcare utilization, due to its dual role in pain relief and mood stabilization. While pregabalin may be preferred in patients with specific comorbidities like functional dyspepsia, duloxetine’s antidepressant effects make it a compelling option for individuals with depression-related FM symptoms. Aim of the study: The study aimed to analyze the current treatment of Fibromyalgia and compare two main treatment methods, duloxetine and pregabalin. Review method: The following keywords, such as fibromyalgia treatment, duloxetine, and pregabalin, have been included in the search phrases used to thoroughly examine research publications available on Pubmed. Conclusion: This review highlights the importance of personalized treatment strategies for FM, integrating pharmacological and non-pharmacological approaches within a biopsychosocial framework. By tailoring therapies to individual needs, clinicians can optimize outcomes and improve patient quality of life.
- 5 April 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 80, 57856
Open AccessTreatment of Fibromyalgia - duloxetine or pregabalin?
Introduction: Fibromyalgia (FM) is a complex and chronic condition characterized by widespread pain, fatigue, and disrupted sleep, often accompanied by mood disturbances and cognitive difficulties. The pathophysiology of FM involves heightened pain sensitivity, altered neurotransmitter levels, and neurochemical imbalances, including elevated substance P and glutamate. Duloxetine, a serotonin-norepinephrine reuptake inhibitor (SNRI), has demonstrated efficacy in managing FM symptoms, particularly pain, functional impairment, and quality of life. Pregabalin, another widely used FM medication, reduces pain by modulating calcium channels and neurotransmitter release, improving sleep and reducing fatigue. Comparative studies indicate that duloxetine may offer broader benefits, including reduced healthcare utilization, due to its dual role in pain relief and mood stabilization. While pregabalin may be preferred in patients with specific comorbidities like functional dyspepsia, duloxetine’s antidepressant effects make it a compelling option for individuals with depression-related FM symptoms. Aim of the study: The study aimed to analyze the current treatment of Fibromyalgia and compare two main treatment methods, duloxetine and pregabalin. Review method: The following keywords, such as fibromyalgia treatment, duloxetine, and pregabalin, have been included in the search phrases used to thoroughly examine research publications available on Pubmed. Conclusion: This review highlights the importance of personalized treatment strategies for FM, integrating pharmacological and non-pharmacological approaches within a biopsychosocial framework. By tailoring therapies to individual needs, clinicians can optimize outcomes and improve patient quality of life.
- Open Access
- 27 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57800
Is dry needling an effective treatment for tennis elbow? A literature review
Introduction:Tennis elbow, or lateral epicondylitis, affects around 1% to 3% of the population, causing pain and functional limitations, yet its exact causes and degenerative mechanisms are still not fully understood. Research indicates that tendinopathy primarily arises from new blood vessel formation and collagen fiber disruptions, while tennis elbow complicates diagnosis and treatment due to a mix of biomechanics, occupational factors, and individual variations. Despite various treatments available for tennis elbow, no single option is universally recognized as superior, with the primary recommendation being to rest from activities that worsen the condition. To alleviate pain after exercising, options include applying ice, using oral or topical NSAIDs, or exploring corticosteroid therapy, with more invasive treatments like dry needling being effective for managing myofascial pain and trigger points when basic methods fall short. Aim: The aim of this article is to explore the underlying mechanisms of tennis elbow and assess the effectiveness of treating it through dry needling. Review methods: A comprehensive analysis of research papers available on PubMed and Google Scholar was undertaken using the searchterms encompassing the following keywords: tennis elbow, lateral epicondylitis, dry needling, tennis elbow pathophysiology. Conclusion: Dry needling has shown success in relieving symptoms of chronic lateral epicondylosis that haven't improved with standard therapies. This method is safe, cost-effective, and can be carried out by practitioners skilled in upper extremity anatomy and rehabilitation, but further extensive research with larger sample sizes, randomization, and control groups is needed to more accurately assess the effectiveness of dry needling for treating tendinopathies.
- 27 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Quality in Sport
- Vol. 37, 57800
Open AccessIs dry needling an effective treatment for tennis elbow? A literature review
Introduction:Tennis elbow, or lateral epicondylitis, affects around 1% to 3% of the population, causing pain and functional limitations, yet its exact causes and degenerative mechanisms are still not fully understood. Research indicates that tendinopathy primarily arises from new blood vessel formation and collagen fiber disruptions, while tennis elbow complicates diagnosis and treatment due to a mix of biomechanics, occupational factors, and individual variations. Despite various treatments available for tennis elbow, no single option is universally recognized as superior, with the primary recommendation being to rest from activities that worsen the condition. To alleviate pain after exercising, options include applying ice, using oral or topical NSAIDs, or exploring corticosteroid therapy, with more invasive treatments like dry needling being effective for managing myofascial pain and trigger points when basic methods fall short. Aim: The aim of this article is to explore the underlying mechanisms of tennis elbow and assess the effectiveness of treating it through dry needling. Review methods: A comprehensive analysis of research papers available on PubMed and Google Scholar was undertaken using the searchterms encompassing the following keywords: tennis elbow, lateral epicondylitis, dry needling, tennis elbow pathophysiology. Conclusion: Dry needling has shown success in relieving symptoms of chronic lateral epicondylosis that haven't improved with standard therapies. This method is safe, cost-effective, and can be carried out by practitioners skilled in upper extremity anatomy and rehabilitation, but further extensive research with larger sample sizes, randomization, and control groups is needed to more accurately assess the effectiveness of dry needling for treating tendinopathies.
- Open Access
- 9 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 77, 56674
Radiofrequency thermocoagulation of Gasserian ganglion in trigeminal neuralgia
Introduction: Trigeminal neuralgia (TN) is a form of neuropathic pain that targets the fifth cranial nerve, leading to intense facial pain that can significantly impact one’s quality of life. This condition typically manifests as recurring episodes of sharp, unilateral pain along one or more branches of the trigeminal nerve.The exact mechanism of trigeminal neuralgia remains largely unknown. Most pain attacks are triggered by certain stimuli in the areas served by the trigeminal nerve. One possible treatment approach for trigeminal neuralgia is radiofrequency thermocoagulation. Aim: The aim of this article is to explore the underlying mechanisms of trigeminal neuralgia and assess the effectiveness of treating it through radiofrequency thermocoagulation of the Gasserian ganglion. Review methods: A comprehensive analysis of research papers available on PubMed and Google Scholar was undertaken using the searchterms encompassing the following keywords: trigeminal neuralgia / Gasserian ganglion radiofrequency thermal therapy/ radiofrequency thermal coagulation/ radiofrequency trigeminal rhizotomy/ trigeminal neuralgia mechanism. Conclusion: The exact mechanisms behind trigeminal neuralgia are still unclear, but several theories suggest that factors such as inflammation, ion channel dysfunction, neuroinflammatory conditions, or bioresonance issues may be involved. Radiofrequency Thermocoagulation (RFT) has proven to be an effective option for easing pain in individuals suffering from Trigeminal Neuralgia. Research indicates that RFT not only significantly reduces pain initially but also provides a prolonged period of relief post-procedure. The temperature achieved during radiofrequency treatments is a key factor in determining the effectiveness of RFT.
- 9 January 2025
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 77, 56674
Open AccessRadiofrequency thermocoagulation of Gasserian ganglion in trigeminal neuralgia
Introduction: Trigeminal neuralgia (TN) is a form of neuropathic pain that targets the fifth cranial nerve, leading to intense facial pain that can significantly impact one’s quality of life. This condition typically manifests as recurring episodes of sharp, unilateral pain along one or more branches of the trigeminal nerve.The exact mechanism of trigeminal neuralgia remains largely unknown. Most pain attacks are triggered by certain stimuli in the areas served by the trigeminal nerve. One possible treatment approach for trigeminal neuralgia is radiofrequency thermocoagulation. Aim: The aim of this article is to explore the underlying mechanisms of trigeminal neuralgia and assess the effectiveness of treating it through radiofrequency thermocoagulation of the Gasserian ganglion. Review methods: A comprehensive analysis of research papers available on PubMed and Google Scholar was undertaken using the searchterms encompassing the following keywords: trigeminal neuralgia / Gasserian ganglion radiofrequency thermal therapy/ radiofrequency thermal coagulation/ radiofrequency trigeminal rhizotomy/ trigeminal neuralgia mechanism. Conclusion: The exact mechanisms behind trigeminal neuralgia are still unclear, but several theories suggest that factors such as inflammation, ion channel dysfunction, neuroinflammatory conditions, or bioresonance issues may be involved. Radiofrequency Thermocoagulation (RFT) has proven to be an effective option for easing pain in individuals suffering from Trigeminal Neuralgia. Research indicates that RFT not only significantly reduces pain initially but also provides a prolonged period of relief post-procedure. The temperature achieved during radiofrequency treatments is a key factor in determining the effectiveness of RFT.
- Open Access
- 7 December 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 75
Influence of The Anabolic Steroid Usage on The Physical Health: A Review
Introduction: Anabolic steroids are synthetic derivatives of testosterone commonly used to enhance athletic performance and physical appearance. Despite their popularity, their non-medical use is associated with significant health risks. This review aims to synthesize current knowledge on the impact of anabolic steroid use on physical health, emphasizing cardiovascular, hepatic, endocrine, and musculoskeletal systems, as well as broader systemic effects. Materials and Methods: A systematic literature review was conducted using peer-reviewed articles from databases such as PubMed, Scopus, and Google Scholar published between 2000 and 2023. Studies were selected based on relevance, with particular focus on human clinical trials, observational studies, and meta-analyses. Keywords included "anabolic steroids," "health effects," "cardiovascular risk," and "endocrine disruption." Results: Anabolic steroid use is linked to increased cardiovascular risks, liver dysfunction, endocrine disturbances, and musculoskeletal injuries. Key effects include hypertension, hepatotoxicity, testosterone suppression, infertility, and tendon injuries. Psychological impacts such as aggression and mood changes were also observed. Conclusions: Anabolic steroid use poses significant risks to multiple organ systems and overall health. Despite widespread awareness of these dangers, misuse persists, often driven by societal pressures and misinformation. Healthcare providers should prioritize prevention through education, early intervention, and support for individuals at risk. Future research should focus on long-term effects and effective strategies for harm reduction.
- 7 December 2024
- Published by Uniwersytet Mikolaja Kopernika/Nicolaus Copernicus University in Journal of Education, Health and Sport
- Vol. 75
Open AccessInfluence of The Anabolic Steroid Usage on The Physical Health: A Review
Introduction: Anabolic steroids are synthetic derivatives of testosterone commonly used to enhance athletic performance and physical appearance. Despite their popularity, their non-medical use is associated with significant health risks. This review aims to synthesize current knowledge on the impact of anabolic steroid use on physical health, emphasizing cardiovascular, hepatic, endocrine, and musculoskeletal systems, as well as broader systemic effects. Materials and Methods: A systematic literature review was conducted using peer-reviewed articles from databases such as PubMed, Scopus, and Google Scholar published between 2000 and 2023. Studies were selected based on relevance, with particular focus on human clinical trials, observational studies, and meta-analyses. Keywords included "anabolic steroids," "health effects," "cardiovascular risk," and "endocrine disruption." Results: Anabolic steroid use is linked to increased cardiovascular risks, liver dysfunction, endocrine disturbances, and musculoskeletal injuries. Key effects include hypertension, hepatotoxicity, testosterone suppression, infertility, and tendon injuries. Psychological impacts such as aggression and mood changes were also observed. Conclusions: Anabolic steroid use poses significant risks to multiple organ systems and overall health. Despite widespread awareness of these dangers, misuse persists, often driven by societal pressures and misinformation. Healthcare providers should prioritize prevention through education, early intervention, and support for individuals at risk. Future research should focus on long-term effects and effective strategies for harm reduction.